Lightning Lecture – Syphilis by Landon Pehle
- Treponema pallidum
- “The Great Imitator”
- Stages
- Primary – painless chancre
- Secondary – rash, lymphadenophty, condyloma lata
- Tertiary – meningitis, aortitis, aneurysms, argyll robertson pupil
- Congenital syphilis
- Testing
- PRP/VDRL (1st line screening)
- FTA-ABS (specific testing)
- Darkfield microscopy
- USPSTF recommends screening in high risk groups
- LP in neurologic, ocular, latent syphilis, HIV coinfection
- Treatment
- Penicillin G
- Jarisch-Herxheiner reaction
- Desensitization
- Penicillin G
Lightning Lecture – Botulism by Madison Wilson
- Clostridium botulinum
- Spores
- Found in soil, water
- Anareobic
- DDX for MG, GBS, tick paralysis, hypothyroid
- Botulism with no CNS effects
- Workup
- Neutralization assay is gold standard
- CT head
- Basic lab work
- LP
- CDC algorithm for initiating treatment
- Equine derived antitoxin
- Admit to ICU
- Airway watch, NG tube, foley catheter
- Recovery is slow
- Infantile botulism
- pH is higher in GI tract, easier for spores to colonize and release in large intestine
- Flaccid paralysis, loss of head control, respiratory failure, loss of reflexes
- Human based botulism IG
- Wound botulism
- In vivo toxin
- Treat with debridement, penicillin, and antitoxin
- Inhalation botulism
- Aerosol for bioterrorism
Infectious Recommendations from Pharmacy – Dr. Hannah Moore
- Sepsis
- 30CC/kilo fluids
- Empiric antibiotic therapy
- Assess risk factors
- Previous + micro
- Previous resistance?
- MRSA – Vanc (IV), Doxy (PO)
- Pseudomonas – Zosyn (IV), Cefepime (IV), Cipro/Levaquin (PO)
- Bacterial meningitis
- S pneumo, N meningitides, listeria, GBS, H influenza, HSV, VZV
- CSF findings – bacterial vs viral vs fungal
- Empiric therapy
- Ceftriaxone, vanc, ampicillin, acyclovir
- Steroids
- Early treatment with decadron improvs outcomes wacute bacterial meningitis
- 10mg Q6
- Bacterial PNA
- S pneumo, N meningitides, listeria, GBS, H influenza, mycoplasma, chlamydia
- Outpatient therapy
- No comorbidities – amoxicillin or doxy, or macrolide
- Comorbities – augmentin or cephalosporin and macrolide or doxy or respiratory fluoroquinolone
- Inpatient therapy
- Non severe vs severe
- See IDSA guidelines, multiple therapy options given patients history, severity
- Non severe vs severe
- Intraabdominal infections
- Classifications – uncomplicated vs complicated
- E coli, proteus, bacteroids, kleibsiella, bacteroides
- Empiric therapy
- Based on severity (mild to high risk)
- See IDSA guidelines, usually recommending combination therapy with flagyl
- Based on severity (mild to high risk)
- UTI
- Classifications – uncomplicated vs complicated
- Asymptomatic bacteriuria
- Treat pregnant women, patient undergoing urologic procedures, patient with kidney transplant w/n 3 months
- E coli, klebsiella, proteus, pseudomonas, enterococcus, staph, enterobacter
- Empiric therapy
- See IDSA guidelines
- Skin/soft tissue infections
- Staph, strep, clostridial, aeromonas
- See IDSA guidelines
- Hypersensitivty reactions
- Type 1 – IgE, anaphylaxis
- Type 4 – T cell mediated, SJS/TEN
- Penicillin desensitization in the ED
Sepsis – Dr Hugh Shoff
- Hospital scoring
- Patient safety measures and trends
Infective endocarditis – Dr Jarred Thomas
- Most common site of infection – tricuspid valve
- Most common bacteria – S aureus
- Highest risk factor – previous IE
- Average age of infection is now increasing
- Current high risk: MRSA, prosthetic valves, ESRD, IV drug use
- Acute vs subacute
- Systemic issues from IE based on left vs right side infection
- Blood cultures
- Ideally three sets as well as fungal culture
- Do not obtain from port site
- Treatment
- Abx
- Surgery
- Valvular conditions that needs PPX as established by AHA 2021 Guidelines